Satsuma Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q1 2023.
  • Satsuma Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 33.2M shares, a 5.09% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32M shares, a 9.77% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 33.2M +1.61M +5.09% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 32M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 31.9M +326K +1.03% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 31.6M +23.5K +0.08% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 31.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 31.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 31.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.